CING

Conviction 49HealthcareScan · Mon, Aug 10, 2026

Bearish harami

CING$5.26-1.50%

ResistanceSupportVol 14Insider buy

Vol MA14 150.84K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Cingulate Inc.PHARMACEUTICAL PREPARATIONSwww.cingulate.com ↗

Price5.26

Change-1.50%

Gap-1.31%

Rel volume1.71×

Avg volume171.25K

Avg $ vol815.69K

SMA 204.77

SMA 504.83

SMA 2005.13

Price vs 50+9.00%

Price vs 200+2.63%

MA stackmixed

50/200 cross—

Supertrendup · 4.37

RSI (14)62

MACD hist0.08

MACD crossbull · 6d

Stoch %K / %D91 / 94

ADX (14)13

+DI / −DI23 / 15

RSI divergence—

MACD divergence—

ATR %+5.82%

ADR %5.86%

52w high11.66

52w low3.33

From 52w high-54.89%

Above 52w low+57.96%

New 52w highNo

SqueezeOff

Bollinger width20.10%

%B1.01

Donchian pos91.42%

Donchian high5.36

Donchian low4.20

AVWAP (52w high)5.39

vs AVWAP high-2.50%

AVWAP (52w low)4.60

vs AVWAP low+14.41%

OBV trendUp

Chaikin MF (20)0.10

Today vs 20d1.71×

Avg vol (14d)150.84K

Avg vol (20d)171.25K

Avg $ vol (20d)815.69K

Market cap—

RS 3m (vs SPY)-3.59%

RS 6m (vs SPY)-31.83%

RS line new highNo

Trend template4/8

Technical rank51.5

1 week+8.90%

1 month+7.13%

3 months-0.19%

6 months-31.69%

1 year+24.94%

YTD+20.09%

P/E-3.15

P/B3.74

P/S—

P/FCF-4.06

EPS-4.44

Div yield—

ROE-119.00%

ROA-72.74%

Debt/Eq—

Current2.55

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-35.57%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value44.74M

Revenue—

Net income-9.31M

Gross profit—

Free cash flow-17.41M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out13.47M

Employees14

ListedWed, Dec 8, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank51.5 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBearish harami

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CING

All disclosures →

No recent disclosed trades by Congress in CING. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CING · 4 buys

Insider	Side	Shares	Value	Traded	Filed
Hargroves Thomas Jeffrey Director · Stock Option (right to Buy) · 2026-03-09	Grant	15K	$0	2026-03-09	2026-06-08
Hargroves Thomas Jeffrey Director · Common Stock · 2026-02-13	Buy	97.28K	$490K	2026-02-13	2026-06-08
Hargroves Thomas Jeffrey Director · Warrant to Purchase Common Stock · 2026-02-13	Buy	77.82K	$8K	2026-02-13	2026-06-08
Silva Raul R. EVP and CSO · Stock Option (right to Buy) · 2026-03-31	Grant	3.42K	$0	2026-03-31	2026-05-08

SEC filings

EDGAR filings in CING · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.